A 2026 cardioprotection study using a permanent LAD coronary artery ligation model in Sprague-Dawley rats evaluated GHRP-6 at 0.4 mg/kg (established minimum effective dose for inotropic enhancement)
Some private employers and insurers cover GLP-1s for obesity, but most have dropped coverage because of the cost
Semaglutide's most common side effects are gastrointestinal (nausea, vomiting, constipation) rather than lipid-related
The amount prescribed may vary depending on the reason for treatment, an individuals hormone levels, age, body weight, response to therapy, and the prescribing healthcare providers clinical judgment
Host events: Run open days, fitness challenges, or wellness workshops specifically for GLP-1 users and those interested in sustainable weight loss
Do not use this medicine after the expiry date which is stated on the label and carton after EXP